
Understanding the Risks of Investing in Moleculin Biotech Inc (MBRX)
Moleculin Biotech Inc’s recent filing unveils that its Chief Financial Officer Foster Jonathan P. acquired Company’s shares for reported $100000.0
Moleculin Biotech Inc’s recent filing unveils that its Chief Financial Officer Foster Jonathan P. acquired Company’s shares for reported $100000.0
In a filing, Moleculin Biotech Inc revealed its Chief Financial Officer Foster Jonathan P. acquired Company’s shares for reported $100000.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Moleculin Biotech Inc’s recent filing unveils that its Chief Financial Officer Foster Jonathan P. acquired Company’s shares for reported $100000.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Moleculin Biotech Inc’s recent filing unveils that its Chief Financial Officer Foster Jonathan P. acquired Company’s shares for reported $100000.0
Moleculin Biotech Inc’s recent filing unveils that its Chief Financial Officer Foster Jonathan P. acquired Company’s shares for reported $100000.0